A recent poll given to doctors showed that while they admit having some effect on healthcare costs, they felt the majority of health price control remained in the hands of lawyers, health insurance companies, hospitals, pharmaceutical companies, and patients.
A recent poll given to doctors showed that while they admit having some effect on healthcare costs, they felt the majority of health price control remained in the hands of lawyers, health insurance companies, hospitals, pharmaceutical companies, and patients.
Researchers at the Mayo Clinic found that out of 2,500 doctors, 59% believed they had some responsibility in holding down healthcare costs, while only 36% voiced having a major role. More than half of those polled physicians agreed that the 5 other stakeholder groups carried a “major responsibility.”
“What physicians are trying to tell us is that they don’t see themselves as necessarily any more responsible for healthcare costs than all of those stakeholders,” said Dr Jon Tilburt, associate professor at the Mayo Clinic and study author. “They see themselves as a contributor, not a main contributor.”
The researchers argue that it may be necessary to phase in more aggressive financial changes. With monitoring, they could ensure the integrity of clinical relationships would not be infringed upon.
"This is a denial of responsibility," stated Ezekiel Emanuel, MD, PhD, and Andrew Steinmetz, both from the University of Pennsylvania in Philadelphia. "Of course, physicians do not want to be blamed for the country's major problem. But can they really be both the captain of the healthcare ship and cede responsibility for cost control to almost everyone else?"
Dr Emanuel added that physicians must accept and take responsibility for controlling healthcare costs. With 85% of respondents agreeing that "trying to contain costs is the responsibility of every physician," the group’s findings suggest that it might take a larger policy reform in physician payment models to successfully encourage value-based, quality-driven performance.
“[Physicians] are most enthusiastic about those cost-containing strategies that improve the quality of care, that bring evidence to the bedside, and that are a clear win-win for the doctor, the patient, and the health system," Tilburt said in a recent interview. "They get more nervous when their bottom line is at stake."
Around the Web
Study: Doctors Look To Others To Curb Health Costs
Study: Doctors Look To Others To Play Biggest Role In Curbing Health Costs [Kaiser Health News]
Docs Point to Others to Cut Health Costs [MedPage Today]
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Forging a Patient-Centric Path to Revolutionize and Redefine Value-Based Care
April 30th 2024Optum Life Sciences and Takeda Pharmaceuticals are partnering on an innovative virtual care pilot program for inflammatory bowel disease meant to both continue the mission of the current value-based health care landscape and raise the bar for personalized care delivery optimization.
Read More
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More